Stay updated on Pembrolizumab in Biliary Tract Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Biliary Tract Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The update appears to be formatting changes to the Study Details page without altering core trial information (eligibility criteria, endpoints, status, or enrollment); these differences are cosmetic and do not modify the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T20:53:00.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    4%
    Check dated 2025-10-06T05:11:42.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T02:58:44.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.
    Difference
    0.3%
    Check dated 2025-09-14T19:00:01.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.3%
    Check dated 2025-09-07T14:23:11.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and specific location details in Seoul, South Korea, while also removing previous location descriptors and certain medical terms related to biliary tract cancer and treatment options.
    Difference
    2%
    Check dated 2025-08-31T11:45:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Biliary Tract Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.